GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (NYSE:NGVT) » Definitions » EBIT

Ingevity (Ingevity) EBIT : $83 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Ingevity EBIT?

Ingevity's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-128 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $83 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ingevity's annualized ROC % for the quarter that ended in Dec. 2023 was 1.15%. Ingevity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -43.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ingevity's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.60%.


Ingevity EBIT Historical Data

The historical data trend for Ingevity's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity EBIT Chart

Ingevity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 283.70 282.20 214.50 331.40 83.20

Ingevity Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.00 84.70 70.50 55.90 -127.90

Competitive Comparison of Ingevity's EBIT

For the Specialty Chemicals subindustry, Ingevity's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ingevity's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ingevity's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ingevity's EV-to-EBIT falls into.



Ingevity EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ingevity  (NYSE:NGVT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ingevity's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=35.6 * ( 1 - 24.16% )/( (2398.6 + 2282.7)/ 2 )
=26.99904/2340.65
=1.15 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ingevity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-511.6/( ( (868.7 + max(366.3, 0)) + (829.3 + max(273.9, 0)) )/ 2 )
=-511.6/( ( 1235 + 1103.2 )/ 2 )
=-511.6/1169.1
=-43.76 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(216.6 + 386.7 + 46.7) - (283.7 + 0 + 5.6843418860808E-14)
=366.3

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(182 + 308.8 + 42.9) - (244.7 + 0 + 15.1)
=273.9

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ingevity's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=83.2/3198.588
=2.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ingevity EBIT Related Terms

Thank you for viewing the detailed overview of Ingevity's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ingevity (Ingevity) Business Description

Traded in Other Exchanges
Address
4920 O'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America.
Executives
Christine Stunyo officer: SVP, Chief HR Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
White Richard Allen Jr officer: SVP, Perf Chem and Pres, ISPT 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405
Phillip John Platt officer: VP, CAO & Corporate Controller 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Woodcock Stuart Edward Jr. officer: EVP, President Perf Materials 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Bruce D. Hoechner director 2225 W CHANDLER BLVD, CHANDLER AZ 85224
Erik Spencer Ripple officer: Chief Growth & Innov Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
Benjamin G. Wright director 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
William J Slocum director C/O INCLUSIVE CAPITAL PARTNERS, L.P., 1170 GORGAS AVENUE, SAN FRANCISCO CA 94129
J Michael Fitzpatrick director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612-4662
Diane H. Gulyas director C/O EXPEDITORS, 1015 THIRD AVENUE, SEATTLE WA 98104
Jean S Blackwell director
Frederick J Lynch director C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Luis M Fernandez-moreno director ASHLAND INC., 8145 BLAZER DRIVE, WILMINGTON DE 19808
Karen G Narwold director ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Steven Paul Hulme officer: SVP, Perf Chem and Pres, EP 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405